Home › Trial NCT03387332
APG-1252 in Patients With SCLC or Advanced Solid Tumors
- Trial IDNCT03387332
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorAscentage Pharma Group Inc.
- Enrollment24
- Start date2017-12-01
- ConditionsSmall Cell Lung Cancer and Other Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.